Gagnon Advisors’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Gagnon Advisors’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-102,594	Closed	-$9.23K	–	28
2024 Q1	$9.23K	Hold	102,594	–	–	0.01%	27
2023 Q4	$12.3K	Hold	102,594	–	–	0.01%	26
2023 Q3	$22.6K	Hold	102,594	–	–	0.02%	28
2023 Q2	$25.6K	Hold	102,594	–	–	0.02%	29
2023 Q1	$25.9K	Hold	102,594	–	–	0.02%	28
2022 Q4	$41K	Hold	102,594	–	–	0.03%	29
2022 Q3	$45K	Hold	102,594	–	–	0.03%	32
2022 Q2	$78K	Hold	102,594	–	–	0.05%	33
2022 Q1	$207K	Hold	102,594	–	–	0.1%	32
2021 Q4	$343K	Hold	102,594	–	–	0.14%	32
2021 Q3	$354K	Buy	+102,594	New	+$316K	0.14%	33

Gagnon Advisors's SLGCW Position: Q2 2024 in Review

Gagnon Advisors sold out of SomaLogic, Inc. Warrant (SLGCW) in Q2 2024, closing a stake of 102,594 shares — an estimated $9.23K sold.

Gagnon Advisors first reported a position in SLGCW in Q3 2021 and held it in 11 quarters. The position peaked at $354K in Q3 2021. 1 fund tracked by Wall St. Rank holds SLGCW as of Q2 2024.

Gagnon Advisors reported no remaining SomaLogic, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Gagnon Advisors sold 102,594 SomaLogic, Inc. Warrant shares in Q2 2024, an estimated $9.23K.
Gagnon Advisors first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 11 quarters.
Gagnon Advisors's SomaLogic, Inc. Warrant position peaked at $354K in Q3 2021.
1 fund tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q2 2024.

Based on Gagnon Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.